Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Idera Pharmaceuticals Inc (NASDAQ:IDRA)

1.60
Delayed Data
As of May 24
 +0.07 / +4.58%
Today’s Change
1.19
Today|||52-Week Range
4.42
-48.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues51.0K47.0K73.0K249.0K
 
 
 
 
 
Depreciation And Amortization251.0K137.0K206.0K488.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses19.7M18.1M38.6M48.6M
 
 
 
 
 
Research And Development13.7M10.5M27.5M33.7M
 
 
 
 
 
Total Operating Expenses20.0M18.2M38.8M49.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.9M-18.2M-38.8M-48.8M
 
 
 
 
 
Extraordinary Credit675.0K0.00--0.00
 
 
Interest Expense On Debt0.00----105.0K
 
 
Other Expenses-23.0K-68.0K71.0K39.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.2M-18.2M-38.6M-48.6M
 
 
 
 
 
Preferred Dividend-3.2M-2.9M-519.0K0.00
 
 
 
 
Net Income-19.2M-18.2M-38.6M-48.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS27.6M43.9M82.8M115.1M
 
 
 
 
 
Shares To Calculate EPS Diluted27.6M43.9M82.8M115.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.81-$0.48-$0.47-$0.42
 
 
 
 
 
EPS Diluted-$0.81-$0.48-$0.47-$0.42